15

February 15, 2015

Interleukin-based therapy for Metastatic tumors: IL-17 increases the expression of PD-1 , a suppressor of activation of T-cells, via up regulation of its target gene, 15/February/2015, 22.53

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Interleukin-based therapy for Metastatic tumors:  IL-17 increases the expression of PD-1 , a suppressor of activation of T-cells, via […]
February 15, 2015

Molecular mechanisms of tumorigenesis: Neurotensin increases the expression of oncogenic protein MDM2, a negative regulator of tumor suppressor p53, via up regulation of its target gene, 15/February/2015, 22.34

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Molecular mechanisms of tumorigenesis: Neurotensin increases the expression of oncogenic protein MDM2, a negative regulator of tumor […]
February 15, 2015

MiRNA-based anticancer therapy: Tumor suppressor MiRNA-218 suppresses the expression L1CAM via down regulation of their target genes, 15/February/20145, 22.04

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, MiRNA-based anticancer therapy: Tumor suppressor MiRNA-218 suppresses the expression L1CAM via down regulation of their target genes, […]
February 15, 2015

Small molecule-based therapy for Visceral pain: TWIST1 decreases visceral pain in patients with Irritable Bowel Syndrome via up regulation of its target gene, 15/February/2015, 21.27

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Small molecule-based therapy for Visceral pain: TWIST1 decreases visceral pain in patients with Irritable Bowel Syndrome […]